We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

HORIBA Medical

HORIBA ABX designs, develops and distributes worldwide, in vitro diagnostic systems for biological analysis in medica... read more Featured Products: More products

Download Mobile App





HORIBA Unveils New Compact Hematology Analyzers with Combined ESR and CBC/Diff

By LabMedica International staff writers
Posted on 31 Jul 2024
Print article
mage: The new compact hematology analyzers with combined ESR and CBC/Diff presented at ADLM 2024 (Photo courtesy of HORIBA)
mage: The new compact hematology analyzers with combined ESR and CBC/Diff presented at ADLM 2024 (Photo courtesy of HORIBA)

HORIBA (Kyoto, Japan) is attending this year's ADLM where the company is showcasing its newly launched compact hematology analyzers that offer combined testing for Erythrocyte Sedimentation Rate (ESR) and complete blood count (CBC)/differential (Diff). HORIBA recently expanded its award-winning compact hematology instrument range with the launch of new models with ESR on board. At ADLM 2024, HORIBA is presenting the new Yumizen H550E (autoloader), H500E CT (closed tube), and Yumizen H500E OT (open tube) which now offer combined testing for CBC/DIFF with ESR results from whole blood in 60 seconds.

Visitors to HORIBA’s booth at ADLM 2024 can learn more about the company’s innovative CoRA (Correlated Rouleaux Analysis) technology that has been used to integrate ESR into its three new analyzers. Combining CBC and 5-population white blood cell differential with rapid ESR, calibrated to the Westergren reference method, on one compact analyzer reduces costs per test and turnaround times, and saves laboratory space. Both the Yumizen H550E and H500E models have been further enhanced by offering new connectivity possibilities for data management through HORIBA’s Yumizen P8000 middleware, along with Yumicare. This remote technical support tool enables secure connection to the instrument to monitor workload, reagent consumption, quality control, and instrument alarms.

Also featuring is the new Yumizen C230 benchtop chemistry analyzer for small-volume laboratories with advanced and user-friendly features. This compact integrated solution is designed with system simplicity for efficient performance and processes tests with disposable cuvettes, enabling efficient resource usage. Paired with high-quality POINTE reagents, the new Yumizen C230 provides reliable test results. In addition, HORIBA is showcasing the new Yumizen C240 chemistry analyzer which is designed with system simplicity for expedient and efficient performance. Ideal for mid-sized to small labs, the Yumizen C240 is a compact and cost-efficient analyzer offering full walk-away capabilities and advanced features such as a washing station and pre-warmed detergent water.

Related Links:
HORIBA

New
Gold Member
ZIKA Virus Test
ZIKA ELISA IgG
Gold Member
Troponin T QC
Troponin T Quality Control
New
Endocrinology Test
LIAISON Growth Hormone Disorders Diagnostic Solution
New
Male Fertility Rapid Test
SP-10

Print article

Channels

Immunology

view channel
Image: Example image of the high-throughput microscopy method used in the study, showing immune cells stained with different fluorescence markers (Photo courtesy of Felix Kartnig/CeMM, MedUni Vienna)

Cutting-Edge Microscopy Technology Enables Tailored Rheumatology Therapies

Rheumatoid arthritis is the most common inflammatory joint disorder, with women three times as likely to suffer from the condition as men. Treatment advances made over the past decades have led to the... Read more

Microbiology

view channel
Image: TriVerity Test is the first and only molecular blood test that can both identify bacterial and viral infections (Photo courtesy of Inflammatix)

30-Minute Sepsis Test Differentiates Bacterial Infections, Viral Infections, and Noninfectious Disease

Despite significant investment in innovation and decades of research, sepsis continues to have a high mortality rate and remains the most expensive diagnosis for healthcare systems. Hospital systems bear... Read more

Industry

view channel
Image: The 24th edition of Medlab Middle East will be held from 3-6 February at the Dubai World Trade Centre (Photo courtesy of Informa Markets)

Medlab Middle East Looks to The Future of Laboratories

The medical laboratory market in the Middle East and Africa (MEA) is expected to experience substantial growth, with projections indicating it could reach USD 473.84 million by 2029, growing at a strong... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.